KLHL40- mediated regulation of Cardiac sarcomeric integrity and Function post- myocardial infarction


Abstract

Background: Cardiac sarcomeric remodeling after myocardial infarction (MI) plays a pivotal role in post-injury cardiac dysfunction, yet the molecular mechanisms governing this process remain incompletely understood.

Objective: We aimed to elucidate the role of Kelch-like protein 40 (KLHL40) in sarcomeric protein remodeling and calcium signaling regulation during the early stages of MI.

Methods: By integrating transcriptomic and proteomic datasets with experimental validation, we characterized dynamic changes in KLHL40 expression and its effects on sarcomeric components. KLHL40 expression was evaluated in human post-MI heart tissues and hypoxia-induced H9C2 cells. Gain- and loss-of-function assays were performed to assess its regulatory effects on key Z-disc-associated proteins (DES, MYOT, CAPZA, TCAP). Protein–protein interactions were identified via His-tag affinity capture using the OCTET NTA system, followed by mass spectrometry and enrichment analysis. Intracellular calcium levels and calpain activity were assessed, and pathways governing KLHL40 degradation were examined using specific inhibitors.

Results: KLHL40 expression was markedly upregulated within 6 hours post-MI and selectively reduced the expression of DES, MYOT, CAPZA, and TCAP—without affecting ACTN2 or FLNC—through calcium accumulation–mediated calpain activation. Interaction network analysis identified ATP2A2 and calcium signaling pathways as downstream targets. Additionally, KLHL40 turnover was regulated via the proteasomal, calpain, autophagic, and O-GlcNAcylation-dependent pathways.

Conclusion: KLHL40 serves as a key modulator of early sarcomeric remodeling following MI by promoting Z-disc protein degradation through calcium-calpain axis activation. These findings suggest KLHL40 as a potential upstream regulator and therapeutic target in post-infarction cardiac remodeling.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.

  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].